keyword
https://read.qxmd.com/read/38645954/right-subclavian-artery-injury-during-catheter-insertion-into-the-right-internal-jugular-vein-treated-with-endovascular-stent-graft-placement-after-balloon-occlusion-test-a-case-report
#1
Yuto Tamaoki, Ryo Kamidani, Hideshi Okada, Takahito Miyake, Kodai Suzuki, Takahiro Yoshida, Keisuke Kumada, Shozo Yoshida, Shinji Ogura
Subclavian artery injuries during internal jugular vein puncture when attempting central venous catheter insertion are rare. A 60-year-old man undergoing treatment for neuromyelitis optica with paralysis and sensory loss developed a complication during catheter placement into his right internal jugular vein for plasmapheresis. His previous physician felt resistance and discontinued the procedure. The patient later developed mild dyspnea and dysphagia. Computed tomography scans indicated thrombus formation and tracheal deviation...
July 2024: Radiology Case Reports
https://read.qxmd.com/read/38640583/favorable-prognosis-in-posterior-circulation-ischemic-stroke-insights-from-a-nationwide-stroke-databank
#2
JOURNAL ARTICLE
Masaomi Koyanagi, Taketo Hatano, Michikazu Nakai, Takenori Ogura, Kazuo Minematsu, Shotai Kobayashi, Kazunori Toyoda
INTRODUCTION: Clinical trials have historically underrepresented patients with posterior circulation ischemic stroke (PCIS). This study aimed to comprehensively assess the clinical characteristics and outcomes of PCIS patients compared to those with anterior circulation ischemic stroke (ACIS). METHODS: A retrospective analysis was conducted using data from the Japan Stroke Data Bank, encompassing 20 years across 130 stroke centers. The study focused on patients diagnosed with PCIS or ACIS...
April 9, 2024: Journal of the Neurological Sciences
https://read.qxmd.com/read/38639848/cytomegalovirus-infection-during-daratumumab-therapy-in-patients-with-newly-diagnosed-multiple-myeloma
#3
JOURNAL ARTICLE
Taku Kikuchi, Nobuhiro Tsukada, Kodai Kunisada, Moe Nomura-Yogo, Yuki Oda, Kota Sato, Tomomi Takei, Mizuki Ogura, Yu Abe, Kenshi Suzuki, Tadao Ishida
The introduction of daratumumab has improved treatment outcomes for multiple myeloma (MM). However, infectious complications are a concern in patients receiving daratumumab. Although some reports have explored the association between daratumumab and cytomegalovirus (CMV) infection, most of these have focused on relapsed or refractory cases, and few describe patients with newly diagnosed MM (NDMM). In this study, we retrospectively analyzed CMV infections in 53 patients with NDMM who received daratumumab as induction therapy...
April 19, 2024: International Journal of Hematology
https://read.qxmd.com/read/38638715/analysis-of-adverse-events-following-phenobarbital-administration-for-pediatric-patients-categorized-by-one-year-age-increments-using-the-u-s-food-and-drug-administration-adverse-event-reporting-system
#4
JOURNAL ARTICLE
Toru Ogura, Chihiro Shiraishi
Background Organ and body development greatly varies in pediatric patients from year to year. Therefore, the incidence of each adverse event following phenobarbital (PB) administration would vary with age. However, in clinical trials, increasing the sample size of pediatric patients in each age group has been challenging. Therefore, previous studies were conducted by dividing pediatric patients into three or four age groups based on the development stage. Although these results were useful in clinical settings, information on adverse events that occurred at one-year age increments in pediatric patients could further enhance treatment and care...
March 2024: Curēus
https://read.qxmd.com/read/38631274/successful-pembrolizumab-treatment-for-microsatellite-instability-high-thymoma-a-case-report
#5
Taichi Kaneko, Akimasa Sekine, Shigeru Komatsu, Ryota Otoshi, Sanshiro Haga, Yoichi Tagami, Takeshi Kaneko, Takashi Ogura
Microsatellite instability (MSI) is a valuable biomarker for immune checkpoint inhibitors. We report the first case of MSI-high thymoma successfully treated with pembrolizumab. This patient had pleural dissemination and was treated with two cytotoxic chemotherapy regimens including carboplatin and paclitaxel combination therapy and pemetrexed, which did not have the desired effect. Because MSI status was high by using the surgical specimen, pembrolizumab was administered as 3rd line chemotherapy. After three courses, the pleural lesions dramatically shrunk, which confirmed a partial response...
April 16, 2024: Respiratory Investigation
https://read.qxmd.com/read/38618087/quantitative-analysis-of-mandibular-cortical-morphology-using-artificial-intelligence-based-computer-assisted-diagnosis-for-panoramic-radiography-on-underlying-diseases-and-dental-status-in-women-over-20-years-of-age
#6
JOURNAL ARTICLE
Ruri Ogawa, Ichiro Ogura
BACKGROUND/PURPOSE: Recently, an artificial intelligence-based computer-assisted diagnosis (AI-CAD) for panoramic radiography was developed to scan the inferior margin of the mandible and automatically evaluate mandibular cortical morphology. The aim of this study was to analyze quantitatively the mandibular cortical morphology using the AI-CAD, especially focusing on underlying diseases and dental status in women over 20 years of age. MATERIALS AND METHODS: 419 patients in women over 20 years of age who underwent panoramic radiography were included in this study...
April 2024: Journal of Dental Sciences
https://read.qxmd.com/read/38616507/electrical-stimulation-of-the-lower-eyelid-orbicularis-oculi-muscle-improves-periocular-dark-circles
#7
JOURNAL ARTICLE
Yukiko Yasui, Hiroshi Kato, Shuntaro Ogura, Masayo Kimura, Aki Kato, Yoshio Hirano, Hiroshi Morita, Tsutomu Yasukawa, Ako Kurachi, Soshi Takeda, Akimichi Morita
BACKGROUND: We developed and tested the safety and efficacy of a cosmetic device to improve dark circles using electrical muscle stimulation of the orbicularis oculi muscle. METHODS: Overall, 18 participants (36 eyes) were studied. The following five items were evaluated before and after the intervention:(1) the Clinical Dark Circle Score using clinical findings and photographs, (2) transcutaneous oxygen partial pressure (TcPO2 ) on the lower eyelid, (3) thermography, (4) two-dimensional laser blood flowmetry, and (5) spectrophotometry...
April 2024: Skin Research and Technology
https://read.qxmd.com/read/38615375/drug-related-pneumonitis-caused-by-amikacin-liposome-inhalation-suspension-one-pathologically-proven-case-and-single-center-experience
#8
JOURNAL ARTICLE
Taichi Kaneko, Ryota Otoshi, Akimasa Sekine, Tomohisa Baba, Chieri Yamada, Sanshiro Haga, Yoichi Tagami, Tomoe Sawazumi, Tamiko Takemura, Shigeru Komatsu, Eri Hagiwara, Takashi Ogura
Amikacin liposome inhalation suspension (ALIS) is known to cause drug-related pneumonitis, which has been described as "hypersensitivity pneumonitis (HP)". However, its clinical and pathological characteristics have never been reported. We retrospectively evaluated 18 patients treated with ALIS. Three (16.7%) patients developed HP-pattern pneumonitis on high-resolution computed tomography. Serum eosinophil counts were elevated up to above 1000/μL in these three patients, which decreased with ALIS discontinuation only...
April 13, 2024: Respiratory Investigation
https://read.qxmd.com/read/38613733/the-molecular-landscape-of-gastric-cancers-for-novel-targeted-therapies-from-real-world-genomic-profiling
#9
JOURNAL ARTICLE
Hiroyuki Yamamoto, Hiroyuki Arai, Ritsuko Oikawa, Kumiko Umemoto, Hiroyuki Takeda, Takuro Mizukami, Yohei Kubota, Ayako Doi, Yoshiki Horie, Takashi Ogura, Naoki Izawa, Jay A Moore, Ethan S Sokol, Yu Sunakawa
BACKGROUND: Panel-based comprehensive genomic profiling is used in clinical practice worldwide; however, large real-world datasets of patients with advanced gastric cancer are not well known. OBJECTIVE: We investigated what differences exist in clinically relevant alterations for molecularly defined or age-stratified subgroups. METHODS: This was a collaborative biomarker study of a real-world dataset from comprehensive genomic profiling testing (Foundation Medicine, Inc...
April 13, 2024: Targeted Oncology
https://read.qxmd.com/read/38611005/-kras-g12c-inhibitor-as-a-treatment-option-for-non-small-cell-lung-cancer-with-comorbid-interstitial-pneumonia
#10
REVIEW
Kazushi Fujimoto, Satoshi Ikeda, Erina Tabata, Taichi Kaneko, Shinobu Sagawa, Chieri Yamada, Kosumi Kumagai, Takashi Fukushima, Sanshiro Haga, Masayuki Watanabe, Tatsuya Muraoka, Akimasa Sekine, Tomohisa Baba, Takashi Ogura
Non-small-cell lung cancer (NSCLC) with comorbid interstitial pneumonia (IP) is a population with limited treatment options and a poor prognosis. Patients with comorbid IP are at high risk of developing fatal drug-induced pneumonitis, and data on the safety and efficacy of molecularly targeted therapies are lacking. KRAS mutations have been frequently detected in patients with NSCLC with comorbid IP. However, the low detection rate of common driver gene mutations, such as epidermal growth factor receptor and anaplastic lymphoma kinase, in patients with comorbid IP frequently results in inadequate screening for driver mutations, and KRAS mutations may be overlooked...
March 28, 2024: Cancers
https://read.qxmd.com/read/38608546/quantification-of-lipoprotein-lipase-in-mouse-plasma-with-a-sandwich-enzyme-linked-immunosorbent-assay
#11
JOURNAL ARTICLE
Takao Kimura, Kazuya Miyashita, Isamu Fukamachi, Kumiko Fukamachi, Kazumi Ogura, Erina Yokoyama, Katsuhiko Tsunekawa, Takumi Nagasawa, Michael Ploug, Ye Yang, Wenxin Song, Stephen G Young, Anne P Beigneux, Katsuyuki Nakajima, Masami Murakami
To support in vivo and in vitro studies of intravascular triglyceride metabolism in mice, we created rat monoclonal antibodies (mAbs) against mouse LPL. Two mAbs, mAbs 23A1 and 31A5, were used to develop a sandwich ELISA for mouse LPL. The detection of mouse LPL by the ELISA was linear in concentrations ranging from 0.31 ng/ml to 20 ng/ml. The sensitivity of the ELISA made it possible to quantify LPL in serum and in both pre-heparin and post-heparin plasma samples (including in grossly lipemic samples)...
April 11, 2024: Journal of Lipid Research
https://read.qxmd.com/read/38607537/risk-stratification-for-synchronous-metachronous-recurrence-after-endoscopic-submucosal-dissection-for-barrett-s-esophageal-adenocarcinoma-using-the-length-of-barrett-s-esophagus
#12
JOURNAL ARTICLE
Yohei Ikenoyama, Ken Namikawa, Manabu Takamatsu, Yusuke Kumazawa, Yoshitaka Tokai, Shoichi Yoshimizu, Yusuke Horiuchi, Akiyoshi Ishiyama, Toshiyuki Yoshio, Toshiaki Hirasawa, Toru Ogura, Junko Fujisaki
BACKGROUND: In Japan, the standard management of Barrett's esophageal adenocarcinoma after endoscopic submucosal dissection involves follow-up; however, multifocal synchronous/metachronous lesions are sometimes observed after endoscopic submucosal dissection. Risk stratification of multifocal cancer facilitates appropriate treatment, including eradication of Barrett's esophagus in high-risk cases; however, no effective risk stratification methods have been established. Thus, we identified the risk factors for multifocal cancer and explored risk-stratified treatment strategies for residual Barrett's esophagus...
April 12, 2024: Esophagus: Official Journal of the Japan Esophageal Society
https://read.qxmd.com/read/38606038/patterns-of-anti-vascular-endothelial-growth-factor-treatment-for-chorioretinal-vascular-diseases-analysis-of-a-nationwide-claims-database-in-japan
#13
JOURNAL ARTICLE
Fumi Gomi, Ryo Kawasaki, Yuichiro Ogura, Kosuke Iwasaki, Tomomi Takeshima, Masafumi Yamabe, Kota Imai
BACKGROUND: Although intravitreal anti-vascular endothelial growth factor therapy is currently considered the first-line treatment for chorioretinal vascular diseases in Japan, information regarding its treatment pattern is scarce. This study investigated the patterns of anti-vascular endothelial growth factor treatment for chorioretinal vascular diseases. METHODS: A health insurance claims database from acute care hospitals was used to estimate treatment intervals and continuation and drop-out rates regarding the anti-vascular endothelial growth factor...
2024: Ann Clin Epidemiol
https://read.qxmd.com/read/38596160/analysis-of-comprehensive-biomolecules-in-critically-ill-patients-via-bioinformatics-technologies
#14
REVIEW
Hisatake Matsumoto, Hiroshi Ogura, Jun Oda
Each patient with a critical illness such as sepsis and severe trauma has a different genetic background, comorbidities, age, and sex. Moreover, pathophysiology changes dynamically over time even in the same patient. Therefore, individualized treatment is necessary to account for heterogeneity in patient backgrounds. Recently, the analysis of comprehensive biomolecular information using clinical specimens has revealed novel molecular pathological classifications called subtypes. In addition, comprehensive biomolecular information using clinical specimens has enabled reverse translational research, which is a data-driven approach to the identification of drug target molecules...
2024: Acute Medicine & Surgery
https://read.qxmd.com/read/38595870/a-case-of-posterior-polar-hemispheric-choroidal-dystrophy-successfully-diagnosed-with-ultra-widefield-fundus-autofluorescence-and-optical-coherence-tomography-angiography
#15
Chinatsu Takano, Shuntaro Ogura, Hironori Ozeki, Tsutomu Yasukawa, Miho Nozaki
We report a case of a 78-year-old man presenting with uncertain visual field loss, ultimately identified as posterior polar hemispheric choroidal dystrophy (PPHCD) using ultra-widefield fundus autofluorescence (FAF) and optical coherence tomography angiography (OCTA). The patient initially reported blurred vision in the left eye and had a previous diagnosis of suspected bilateral normal tension glaucoma based on optic nerve head excavation and static perimetry measurements. Detailed examination revealed suspicious retinal atrophy...
March 2024: Curēus
https://read.qxmd.com/read/38595316/analyzing-the-risk-factors-for-disease-progression-within-2%C3%A2-years-and-histological-transformation-in-patients-treated-with-rituximab-plus-cyclophosphamide-doxorubicin-vincristine-and-prednisone-as-first-line-treatment-a-15-year-follow-up-of-patients-with-advanced
#16
RANDOMIZED CONTROLLED TRIAL
Takashi Watanabe, Yoshihiro Matsuno, Masashi Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, Michinori Ogura, Junya Kuroda, Youko Suehiro, Kunihiro Tsukasaki, Kensei Tobinai, Hirokazu Nagai
Follicular lymphoma (FL) is an indolent lymphoma that becomes aggressive due to histological transformation (HT), leading to reduced survival. Patients with FL have different clinical courses and various treatment options. Some patients exhibit shorter survival and experience disease progression within 24 months of diagnosis/treatment (POD24); the optimal treatment remains an unmet needs. Thus, identifying factors that predict shorter survival is essential to stratify treatment and prolong the survival of patients with FL...
May 2024: Hematological Oncology
https://read.qxmd.com/read/38595266/plasma-proteomics-profile-based-comparison-of-torso-versus-brain-injury-a-prospective-cohort-study
#17
JOURNAL ARTICLE
Jotaro Tachino, Yuki Togami, Hisatake Matsumoto, Tsunehiro Matsubara, Shigeto Seno, Hiroshi Ogura, Jun Oda
INTRODUCTION: Trauma-related deaths and post-traumatic sequelae are a global health concern, necessitating a deeper understanding of the pathophysiology to advance trauma therapy. Proteomics offers insights into identifying and analyzing plasma proteins associated with trauma and inflammatory conditions; however, current proteomic methods have limitations in accurately measuring low-abundance plasma proteins. This study compared plasma proteomics profiles of patients from different acute trauma subgroups to identify new therapeutic targets and devise better strategies for personalized medicine...
April 10, 2024: Journal of Trauma and Acute Care Surgery
https://read.qxmd.com/read/38594325/impact-of-center-volume-on-in-hospital-mortality-in-adult-patients-with-out%C3%A2-of%C3%A2-hospital-cardiac-arrest-resuscitated-using-extracorporeal-cardiopulmonary-resuscitation-a-secondary-analysis-of-the-save-j-ii-study
#18
MULTICENTER STUDY
Kayo Misumi, Yoshihiro Hagiwara, Takuya Kimura, Toru Hifumi, Akihiko Inoue, Tetsuya Sakamoto, Yasuhiro Kuroda, Takayuki Ogura
Recently, patients with out-of-hospital cardiac arrest (OHCA) refractory to conventional resuscitation have started undergoing extracorporeal cardiopulmonary resuscitation (ECPR). However, the mortality rate of these patients remains high. This study aimed to clarify whether a center ECPR volume was associated with the survival rates of adult patients with OHCA resuscitated using ECPR. This was a secondary analysis of a retrospective multicenter registry study, the SAVE-J II study, involving 36 participating institutions in Japan...
April 9, 2024: Scientific Reports
https://read.qxmd.com/read/38593617/nafamostat-mesylate-decreases-skin-flap-necrosis-in-a-mouse-model-of-type-2-diabetes-by-protecting-the-endothelial-glycocalyx
#19
JOURNAL ARTICLE
Yohei Fukuda, Hideshi Okada, Hiroyuki Tomita, Kodai Suzuki, Kosuke Mori, Chihiro Takada, Yuki Kawasaki, Hirotsugu Fukuda, Toru Minamiyama, Ayane Nishio, Takuto Shimada, Ayumi Kuroda, Akihiro Uchida, Keiko Suzuki, Ryo Kamidani, Yuichiro Kitagawa, Tetsuya Fukuta, Takahito Miyake, Takahiro Yoshida, Akio Suzuki, Nobuyuki Tetsuka, Shozo Yoshida, Shinji Ogura
The success rate of flap tissue reconstruction has increased in recent years owing to advancements in microsurgical techniques. However, complications, such as necrosis, are still more prevalent in diabetic patients compared to non-diabetic individuals, presenting an ongoing challenge. To address this issue, many previous studies have examined vascular anastomoses dilation and stability, primarily concerning surgical techniques or drugs. In contrast, in the present study, we focused on microvascular damage of the peripheral microvessels in patients with diabetes mellitus and the preventative impact of nafamostat mesylate...
April 3, 2024: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/38589679/exploratory-analysis-of-serum-her2-extracellular-domain-for-her2-positive-gastric-cancer-treated-with-sox-plus-trastuzumab
#20
JOURNAL ARTICLE
Takeru Wakatsuki, Naoki Ishizuka, Shuichi Hironaka, Keiko Minashi, Shigenori Kadowaki, Masahiro Goto, Hirokazu Shoji, Hidekazu Hirano, Izuma Nakayama, Hiroki Osumi, Mariko Ogura, Keisho Chin, Kensei Yamaguchi, Daisuke Takahari
BACKGROUND: The aim of this study was to explore the clinical utility of serum HER2 extracellular domain (sHER2 ECD) using data from a clinical trial evaluating trastuzumab combined S-1 plus oxaliplatin (SOX) in HER2 positive gastric cancer. METHODS: sHER2 ECD were prospectively measured at baseline and subsequent treatment courses. Based on each quantile point of baseline sHER2 ECD levels and its early changes, patients were divided into two groups and compared clinical outcomes...
April 8, 2024: International Journal of Clinical Oncology
keyword
keyword
3534
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.